Indoco Remedies on Wednesday said the US Food and Drug Administration has approved its Goa plant II, following an inspection in July. “We have received the establishment inspection report from the US FDA for the sterile and solid dosages facility, Goa plant II,” the company said in an exchange filing. Indoco Remedies’ sterile facility manufactures ophthalmics and injectables. Shares of Indoco Remedies were up about 16 per cent at ? 303.9 on the NSE.